TY  - GEN
AU  - Jakubikova,Jana
AU  - Adamia,Sophia
AU  - Kost-Alimova,Maria
AU  - Klippel,Steffen
AU  - Cervi,David
AU  - Daley,John F
AU  - Cholujova,Dana
AU  - Kong,Sun-Young
AU  - Leiba,Merav
AU  - Blotta,Simona
AU  - Ooi,Melissa
AU  - Delmore,Jake
AU  - Laubach,Jacob
AU  - Richardson,Paul G
AU  - Sedlak,Jan
AU  - Anderson,Kenneth C
AU  - Mitsiades,Constantine S
TI  - Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
SN  - 1528-0020
PY  - 2011///0630
KW  - ATP-Binding Cassette Transporters
KW  - genetics
KW  - Angiogenesis Inhibitors
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - Bone Marrow Cells
KW  - cytology
KW  - Cell Division
KW  - drug effects
KW  - Cell Fractionation
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Colony-Forming Units Assay
KW  - Drug Resistance, Neoplasm
KW  - Humans
KW  - Lenalidomide
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Neoplasm Recurrence, Local
KW  - prevention & control
KW  - Neoplastic Stem Cells
KW  - Signal Transduction
KW  - Stromal Cells
KW  - Syndecan-1
KW  - metabolism
KW  - Thalidomide
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2010-02-267344
ER  -